fluconazole has been researched along with Active Hyperemia in 3 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We sought to clarify, using functional and biological approaches, the role of epoxyeicosatrienoic acids, nitric oxide (NO)/reactive oxygen species balance, and endothelin-1 in conduit artery endothelial dysfunction during essential hypertension." | 9.16 | Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension. ( Bellien, J; Dreano, Y; Gutierrez, L; Iacob, M; Joannides, R; Lucas, D; Mercier, A; Monteil, C; Remy-Jouet, I; Thuillez, C; Vendeville, C, 2012) |
| "We sought to clarify, using functional and biological approaches, the role of epoxyeicosatrienoic acids, nitric oxide (NO)/reactive oxygen species balance, and endothelin-1 in conduit artery endothelial dysfunction during essential hypertension." | 5.16 | Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension. ( Bellien, J; Dreano, Y; Gutierrez, L; Iacob, M; Joannides, R; Lucas, D; Mercier, A; Monteil, C; Remy-Jouet, I; Thuillez, C; Vendeville, C, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Qiu, J | 1 |
| Roza, MP | 1 |
| Colli, KG | 1 |
| Dalben, YR | 1 |
| Maifrede, SB | 1 |
| Valiatti, TB | 1 |
| Novo, VM | 1 |
| Cayô, R | 1 |
| Grão-Velloso, TR | 1 |
| Gonçalves, SS | 1 |
| Bellien, J | 1 |
| Iacob, M | 1 |
| Remy-Jouet, I | 1 |
| Lucas, D | 1 |
| Monteil, C | 1 |
| Gutierrez, L | 1 |
| Vendeville, C | 1 |
| Dreano, Y | 1 |
| Mercier, A | 1 |
| Thuillez, C | 1 |
| Joannides, R | 1 |
| Cracowski, JL | 1 |
| Gaillard-Bigot, F | 1 |
| Cracowski, C | 1 |
| Sors, C | 1 |
| Roustit, M | 1 |
| Millet, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)[NCT02584439] | Phase 3 | 30 participants (Anticipated) | Interventional | 2015-10-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for fluconazole and Active Hyperemia
| Article | Year |
|---|---|
Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension.
Topics: 14-alpha Demethylase Inhibitors; Adult; Eicosanoids; Endothelin-1; Endothelium, Vascular; Enzyme Inh | 2012 |
Involvement of cytochrome epoxygenase metabolites in cutaneous postocclusive hyperemia in humans.
Topics: 8,11,14-Eicosatrienoic Acid; Adult; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Female; | 2013 |
1 other study available for fluconazole and Active Hyperemia
| Article | Year |
|---|---|
Candida-associated denture stomatitis: clinical, epidemiological, and microbiological features.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Drug Resistanc | 2023 |